JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2016, Vol. 54 ›› Issue (10): 40-45.doi: 10.6040/j.issn.1671-7554.0.2015.1282
Previous Articles Next Articles
MI Te, QU Chuanqiang, WANG Xiang, YIN Ling, XUE Yuan, DU Yifeng
CLC Number:
[1] Jia J, Wang F, Wei C, et al. The prevalence of dementia in urban and rural areas of China[J]. Alzheimers Dement, 2014, 10(1):1-9. [2] Chan KY, Wang W, Wu JJ, et al. Epidemiology of Alzheimers disease and other forms of dementia in China. 1990-2010: a systematic review and analysis[J]. Lancet, 2013, 381(9882): 2016-2023. [3] Mukhopadhyay A, Sundar U, Adwani S, et al. Prevalence of stroke and post-stroke cognitive impairment in the elderly in Dharavi, Mumbai[J]. J Assoc Physicians India, 2012, 60(60): 29-32. [4] Jacquin A, Binquet C, Rouaud O, et al. Post-stroke cognitive impairment: high prevalence and determining factors in a cohort of mild stroke[J]. J Alzheimers Dis, 2014, 40(4): 1029-1038. [5] Brayne C. The elephant in the room-healthy brains in later life, epidemiology and public health[J]. Nat Rev Neurosci, 2007, 8(3): 233-239. [6] Savva GM, Stephan BC. Alzheimers society vascular dementia systematic review G. Epidemiological studies of the effect of stroke on incident dementia: a systematic review[J]. Stroke, 2010, 41(1): e41-46. [7] Sezer S, Uçar F, Ulusoy EK, et al. Serum amyloid A, fetuin-A, and pentraxin-3 levels in patients with ischemic stroke: novel prognostic biomarkers[J]. Turk J Med Sci, 2014, 44(1): 16-23. [8] Marksteiner J, Imarhiagbe D, Defrancesco M, et al. Analysis of 27 vascular-related proteins reveals that NT-proBNP is a potential biomarker for Alzheimers disease and mild cognitive impairment: a pilot-study[J]. Exp Gerontol, 2014, 50: 114-121. doi:10.1016/j.exger.2013.12.001. [9] Zeng Q, Tao W, Lei C, et al. Etiology and risk factors of posterior circulation infarction compared with anterior circulation infarction[J]. J Stroke Cerebrovasc Dis, 2015, 24(7): 1614-1620. [10] Trollor JN, Smith E, Agars E, et al. The association between systemic inflammation and cognitive performance in the elderly: the Sydney Memory and Ageing Study[J]. Age(Dordr), 2012, 34(5): 1295-1308. [11] Renjen PN, Gauba C, Chaudhari D. Cognitive impairment after stroke[J]. Cureus, 2015, 7(9): e335. doi:10.7759/cureus.335. [12] Stephens S, Kenny RA, Rowan E, et al. Neuropsychological characteristics of mild vascular cognitive impairment and dementia after stroke[J]. Int J Geriatr Psychiatry, 2004, 19(11):1053-1057. [13] Bour A, Rasquin S, Boreas A, et al. How predictive is the MMSE for cognitive performance after stroke?[J]. J Neurol, 2010, 257(4): 630-637. [14] Meng X, DArcy C. Education and dementia in the context of the cognitive reserve hypothesis: a systematic review with meta-analyses and qualitative analyses[J]. PLoS One, 2012, 7(6): e38268. doi:10.1371/journal.pone.0038268. [15] Skogen B, Natvig JB. Degradation of amyloid proteins by different serine proteases[J]. Scand J Immunol, 1981, 14(4): 389-396. [16] Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association[J]. Circulation, 2003, 107(3): 499-511. [17] Pessolano LJ, Sullivan CP, Seidl SE, et al. Trafficking of endogenous smooth muscle cell cholesterol: a role for serum amyloid A and inter-leukin 1β[J]. Arterioscler Thromb Vasc Biol, 2012, 32(11): 2741-2750. [18] Losey P, Ladds E, Laprais M, et al. The role of PPAR activation during the systemic response to brain injury[J]. J Neuroinflammation, 2015, 12(1): 99. doi:10.1186/s12974-015-0295-7. [19] Dong Z, Wu T, Qin W, et al. Serum amyloid A directly accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice[J]. Mol Med, 2011, 17(11-12): 1357-1364. [20] Li B, Dong Z, Liu H, et al. Serum amyloid A stimulates lipoprotein-associated phospholipase A2 expression in vitro and in vivo[J]. Atherosclerosis, 2013, 228(2): 370-379. [21] Elkind MS, Coates K, Tai W, et al. Levels of acute phase proteins remain stable after ischemic stroke[J]. BMC Neurol, 2006, 6: 37. doi:10.1186/1471-2377-6-37. [22] Brea D, Sobrino T, Blanco M, et al. Usefulness of haptoglobin and serum amyloid A proteins as biomarkers for atherothrombotic ischemic stroke diagnosis confirmation[J]. Atherosclerosis, 2009, 205(2): 561-567. [23] Schillinger M, Exner M, Mlekusch W, et al. Inflammation and carotid artery-risk for atherosclerosis study(ICARAS)[J]. Circulation, 2005, 111(17): 2203-2209. |
|